Asking More of Our EHR Systems to Improve Outcomes for Pediatric Patients by Jeffrey S. Barrett

Connect to this object online.

Editorial: Insights in obstetric and pediatric pharmacology: 2021 by Jeffrey S. Barrett

Connect to this object online.

Quantitative system pharmacology as a legitimate approach to examine extrapolation strategies used to support pediatric drug development by Karim Azer, Jeffrey S. Barrett

Connect to this object online.

From Patient to Molecule: In Pursuit of Universal Treatments for TB by Penny M. Heaton, Jeffrey S. Barrett

Connect to this object online.

The Grand Challenges in Obstetric and Pediatric Pharmacology by Anne eZajicek, Jeffrey Scott Barrett

Connect to this object online.

Digital Research Environment(DRE)-enabled Artificial Intelligence (AI) to facilitate early stage drug development by Jeffrey S. Barrett, Solmaz Eradat Oskoui, Scott Russell, Amanda Borens

Connect to this object online.

A Hemodynamic Model to Guide Blood Pressure Control During Deliberate Hypotension with Sodium Nitroprusside in Children by Jeffrey Scott Barrett, Jeffrey Scott Barrett, Sarapee eHirankarn, Nick eHolford, Gregory B Hammer, David R Drover, Carol A Cohane, Brian eAnderson, Erin eDombrowsky, Tammy eReece, Anne eZajicek, Scott eSchulman

Connect to this object online.

Engaging student opinions on vaccine development innovation: Experiences from a "Shark Tank" project by Jeffrey S. Barrett, Jeffrey M. Skolnik, Mary Ingram, Yin‐Ming Kuo, Ann E. Metzloff, Ruizhe Jin, Yuanhan Wu, Nik Kroushl

Connect to this object online.

Considerations for addressing anti‐vaccination campaigns: How did we get here and what can we do about it? by Jeffrey S. Barrett, Scarlett Y. Yang, Kavitha Muralidharan, Victoria Javes, Kemi Oladuja, María Sofía Castelli, Nicole Clayton, Jiaqi Liu, Andre Ramos

Connect to this object online.

Evaluation of sodium nitroprusside for controlled hypotension in children during surgery by David R Drover, Gregory B Hammer, Jeffrey Scott Barrett, Carol A Cohane, Tammy eReece, Anne eZajicek, Scott eSchulman, Scott eSchulman

Connect to this object online.

Landscape analysis for a neonatal disease progression model of bronchopulmonary dysplasia: Leveraging clinical trial experience and real-world data by Jeffrey S. Barrett, Megan Cala Pane, Timothy Knab, William Roddy, Jack Beusmans, Eric Jordie, Kanwaljit Singh, Jonathan Michael Davis, Klaus Romero, Michael Padula, Bernard Thebaud, Mark Turner

Connect to this object online.

Advancing the utilization of real‐world data and real‐world evidence in clinical pharmacology and translational research-Proceedings from the ASCPT 2023 preconference workshop by Jing Liu, Karen Rowland‐Yeo, Almut Winterstein, Simon Dagenais, Qi Liu, Jeffrey S. Barrett, Rui Zhu, Cyrus Ghobadi, Amita Datta‐Mannan, Joy Hsu, Sujatha Menon, Mariam Ahmed, Pooja Manchandani, Paulien Ravenstijn

Connect to this object online.

Quantitative Systems Pharmacology Modeling of Acid Sphingomyelinase Deficiency and the Enzyme Replacement Therapy Olipudase Alfa Is an Innovative Tool for Linking Pathophysiology a... by Chanchala D. Kaddi, Bradley Niesner, Rena Baek, Paul Jasper, John Pappas, John Tolsma, Jing Li, Zachary van Rijn, Mengdi Tao, Catherine Ortemann‐Renon, Rachael Easton, Sharon Tan, Ana Cristina Puga, Edward H. Schuchman, Jeffrey S. Barrett, Karim Azer

Connect to this object online.

A Quantitative Systems Pharmacology Model of Gaucher Disease Type 1 Provides Mechanistic Insight Into the Response to Substrate Reduction Therapy With Eliglustat by Ruth Abrams, Chanchala D. Kaddi, Mengdi Tao, Randolph J. Leiser, Giulia Simoni, Federico Reali, John Tolsma, Paul Jasper, Zachary vanRijn, Jing Li, Bradley Niesner, Jeffrey S. Barrett, Luca Marchetti, M. Judith Peterschmitt, Karim Azer, Susana Neves‐Zaph

Connect to this object online.